Education
About Us
Working with TipRanks
Follow Us
Jeffrey S. Hackman Insider Profile
4 Followers
Jeffrey S. Hackman, Chairman, President, and Chief Executive Officer., Director at Comera Life Sciences Holdings, holds 15.00K shares in Fennec Pharmaceuticals (Ticker: FENC), holds 47.60K shares in Comera Life Sciences Holdings (Ticker: CMRA). Most recently, Jeffrey S. Hackman Bought ― shares of Fennec Pharmaceuticals on May 19, 2025 for an estimated value of 104.60K.
Jeffrey S. Hackman Comera Life Sciences Holdings (CMRA)Chairman, President, and Chief Executive Officer., Director
Comera Life Sciences Holdings (CMRA)
Chairman, President, and Chief Executive Officer., Director
Ranked #77,474 out of 102,674 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-33.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jeffrey S. Hackman holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jeffrey S. Hackman
Jeffrey S. Hackman's Trading History
Comera Life Sciences Holdings
Sep 12, 2022
Chairman, President, and Chief Executive Officer., Director
Informative Buy
98.06K
$476.00
Fennec Pharmaceuticals
May 19, 2025
CEO, Director
Informative Buy
104.60K
$129.90K
List of latest transactions for each holding click on a transaction to see Jeffrey S. Hackman's performance on stock
You May Also Like
Jeffrey S. Hackman insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey S. Hackman?
The percentage of profitable transactions made by Jeffrey S. Hackman is 50%.
What is the average return per transaction made by Jeffrey S. Hackman?
The average return per transaction made by Jeffrey S. Hackman is -33.80%.
What stocks does Jeffrey S. Hackman hold?
Jeffrey S. Hackman holds: CMRA, FENC stocks.
What was Jeffrey S. Hackman’s latest transaction?
Jeffrey S. Hackman latest transaction was an Informative Buy of $104.60K.
What was Jeffrey S. Hackman's most profitable transaction?
Jeffrey S. Hackman’s most profitable transaction was an Informative Buy of FENC stock on May 19, 2025. The return on the trade was 12.80%.
What is Jeffrey S. Hackman's role in Comera Life Sciences Holdings?
Jeffrey S. Hackman's role in Comera Life Sciences Holdings is Chairman, President, and Chief Executive Officer., Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.